Fraser Conrad

945 total citations
25 papers, 748 citations indexed

About

Fraser Conrad is a scholar working on Neurology, Cellular and Molecular Neuroscience and Molecular Biology. According to data from OpenAlex, Fraser Conrad has authored 25 papers receiving a total of 748 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Neurology, 13 papers in Cellular and Molecular Neuroscience and 9 papers in Molecular Biology. Recurrent topics in Fraser Conrad's work include Botulinum Toxin and Related Neurological Disorders (17 papers), Neurological disorders and treatments (15 papers) and Hereditary Neurological Disorders (13 papers). Fraser Conrad is often cited by papers focused on Botulinum Toxin and Related Neurological Disorders (17 papers), Neurological disorders and treatments (15 papers) and Hereditary Neurological Disorders (13 papers). Fraser Conrad collaborates with scholars based in United States, Russia and Türkiye. Fraser Conrad's co-authors include James D. Marks, Jianlong Lou, Dmitri B. Kirpotin, Yongfeng Fan, Bin Liu, Matthew R. Cooperberg, Bin Liu, Daryl C. Drummond, Theresa J. Smith and Jianbo Dong and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Journal of Molecular Biology.

In The Last Decade

Fraser Conrad

24 papers receiving 728 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fraser Conrad United States 16 362 276 251 209 139 25 748
Helen Chung United States 6 502 1.4× 118 0.4× 498 2.0× 38 0.2× 217 1.6× 8 895
Namir J. Hassan United Kingdom 15 382 1.1× 90 0.3× 169 0.7× 36 0.2× 450 3.2× 26 1.1k
Ignacio Gonzales-Gomez United States 8 243 0.7× 25 0.1× 257 1.0× 34 0.2× 139 1.0× 11 656
Carlos Vaccaro United States 8 730 2.0× 47 0.2× 833 3.3× 16 0.1× 98 0.7× 11 1.2k
Gabrielle J. Grundy United Kingdom 15 614 1.7× 65 0.2× 97 0.4× 20 0.1× 287 2.1× 21 985
R A Reisfeld United States 18 805 2.2× 246 0.9× 629 2.5× 16 0.1× 315 2.3× 28 1.3k
Inka Scheffrahn Germany 13 351 1.0× 15 0.1× 272 1.1× 75 0.4× 344 2.5× 13 821
Jamie K. Miller United States 14 568 1.6× 23 0.1× 219 0.9× 22 0.1× 423 3.0× 16 914
Hirokazu Kambara Japan 12 313 0.9× 67 0.2× 65 0.3× 13 0.1× 233 1.7× 17 694

Countries citing papers authored by Fraser Conrad

Since Specialization
Citations

This map shows the geographic impact of Fraser Conrad's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fraser Conrad with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fraser Conrad more than expected).

Fields of papers citing papers by Fraser Conrad

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fraser Conrad. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fraser Conrad. The network helps show where Fraser Conrad may publish in the future.

Co-authorship network of co-authors of Fraser Conrad

This figure shows the co-authorship network connecting the top 25 collaborators of Fraser Conrad. A scholar is included among the top collaborators of Fraser Conrad based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fraser Conrad. Fraser Conrad is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fan, Yongfeng, Jianlong Lou, Christina C. Tam, et al.. (2023). A Three-Monoclonal Antibody Combination Potently Neutralizes BoNT/G Toxin in Mice. Toxins. 15(5). 316–316. 3 indexed citations
2.
Fan, Yongfeng, Zhengda Sun, Fraser Conrad, et al.. (2022). Multicolor fluorescence activated cell sorting to generate humanized monoclonal antibody binding seven subtypes of BoNT/F. PLoS ONE. 17(9). e0273512–e0273512. 3 indexed citations
3.
Takasaka, Naoki, Robert Seed, Anthony Cormier, et al.. (2018). Integrin αvβ8–expressing tumor cells evade host immunity by regulating TGF-β activation in immune cells. JCI Insight. 3(20). 89 indexed citations
4.
Tomic, Milan T., et al.. (2018). Antibody engineering to improve manufacturability. Protein Expression and Purification. 149. 75–83. 9 indexed citations
5.
Garcia-Rodriguez, Consuelo, Isin N. Geren, Jianlong Lou, et al.. (2018). A Three Monoclonal Antibody Combination Potently Neutralizes Multiple Botulinum Neurotoxin Serotype E Subtypes. Toxins. 10(3). 105–105. 35 indexed citations
6.
Fan, Yongfeng, Consuelo Garcia-Rodriguez, Jianlong Lou, et al.. (2017). A three monoclonal antibody combination potently neutralizes multiple botulinum neurotoxin serotype F subtypes. PLoS ONE. 12(3). e0174187–e0174187. 25 indexed citations
7.
Fan, Yongfeng, Jason R. Barash, Jianlong Lou, et al.. (2016). Immunological Characterization and Neutralizing Ability of Monoclonal Antibodies Directed Against Botulinum Neurotoxin Type H. The Journal of Infectious Diseases. 213(10). 1606–1614. 31 indexed citations
8.
Fan, Yongfeng, Isin N. Geren, Jianbo Dong, et al.. (2015). Monoclonal Antibodies Targeting the Alpha-Exosite of Botulinum Neurotoxin Serotype/A Inhibit Catalytic Activity. PLoS ONE. 10(8). e0135306–e0135306. 17 indexed citations
9.
Fan, Yongfeng, Jianbo Dong, Jianlong Lou, et al.. (2015). Monoclonal Antibodies that Inhibit the Proteolytic Activity of Botulinum Neurotoxin Serotype/B. Toxins. 7(9). 3405–3423. 19 indexed citations
10.
Tomic, Milan T., Carlos A. García, Jianlong Lou, et al.. (2013). Recombinant monoclonal-antibody-based antitoxins for treatment of types A, B, and E botulism. Toxicon. 68. 99–100.
11.
Zhou, Yu, Brian D. Harms, Hao Zou, et al.. (2012). Impact of Intrinsic Affinity on Functional Binding and Biological Activity of EGFR Antibodies. Molecular Cancer Therapeutics. 11(7). 1467–1476. 54 indexed citations
12.
García‐Rodríguez, Carmen, et al.. (2012). Engineered domain-based assays to identify individual antibodies in oligoclonal combinations targeting the same protein. Analytical Biochemistry. 430(2). 141–150. 24 indexed citations
13.
Wang, Yong, Zhen–Yong Keck, Jinming Xia, et al.. (2011). Affinity Maturation to Improve Human Monoclonal Antibody Neutralization Potency and Breadth against Hepatitis C Virus. Journal of Biological Chemistry. 286(51). 44218–44233. 27 indexed citations
14.
Conrad, Fraser, et al.. (2011). Domain-based assays of individual antibody concentrations in an oligoclonal combination targeting a single protein. Analytical Biochemistry. 421(2). 351–361. 22 indexed citations
15.
Dong, Jianbo, Aaron A. Thompson, Yongfeng Fan, et al.. (2010). A Single-Domain Llama Antibody Potently Inhibits the Enzymatic Activity of Botulinum Neurotoxin by Binding to the Non-Catalytic α-Exosite Binding Region. Journal of Molecular Biology. 397(4). 1106–1118. 75 indexed citations
16.
García‐Rodríguez, Carmen, Isin N. Geren, Jianlong Lou, et al.. (2010). Neutralizing human monoclonal antibodies binding multiple serotypes of botulinum neurotoxin. Protein Engineering Design and Selection. 24(3). 321–331. 59 indexed citations
17.
Conrad, Fraser, Xiaodong Zhu, Xin Zhang, et al.. (2009). Human antibodies targeting cell surface antigens overexpressed by the hormone refractory metastatic prostate cancer cells: ICAM-1 is a tumor antigen that mediates prostate cancer cell invasion. Journal of Molecular Medicine. 87(5). 507–514. 25 indexed citations
18.
Liu, Bin, et al.. (2007). Recombinant full-length human IgG1s targeting hormone-refractory prostate cancer. Journal of Molecular Medicine. 85(10). 1113–1123. 34 indexed citations
19.
Drummond, Daryl C., Fraser Conrad, Mark Hayes, et al.. (2007). Anti-CD166 single chain antibody-mediated intracellular delivery of liposomal drugs to prostate cancer cells. Molecular Cancer Therapeutics. 6(10). 2737–2746. 67 indexed citations
20.
Liu, Bin, Fraser Conrad, Matthew R. Cooperberg, Dmitri B. Kirpotin, & James D. Marks. (2004). Mapping Tumor Epitope Space by Direct Selection of Single-Chain Fv Antibody Libraries on Prostate Cancer Cells. Cancer Research. 64(2). 704–710. 81 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026